Lupin launches triple-combination COPD inhaler after Indian regulatory approval
Free synopsis
Lupin has launched Formoflo-G MDI in India following approval from the Drug Controller General of India. Its October 6 announcement describes the product as the world’s first fixed-dose triple-combination metered-dose inhaler of this kind for chronic obstructive pulmonary disease.
The full article is available to subscribers.
Products and related news
Request a free newsletter trial covering your products and business interests.
Request a free trialOur team will confirm activation and access. A trial request does not automatically unlock this article.